The impact of COVID-19 on hepatitis C services
Globally, the COVID-19 pandemic has led to significant, unprecedented changes to the delivery of healthcare and social services. Many health services supporting hepatitis C prevention, testing, treatment and ongoing liver care have shifted to virtual delivery, suspended in-person services, or have had staff and resources reassigned to the COVID-19 response. Public health measures used to control COVID-19’s spread have also made it more difficult to access services and supports, particularly the most marginalized populations.
There is a real concern that these changes in healthcare have led to delays in hepatitis C diagnosis, treatment and ongoing care, with potentially severe health consequences for people who have hepatitis C.
This webinar, in partnership with CanHepC, will explore the impact of COVID-19 on the hepatitis C cascade of care, health outcomes for people living with or cured of hepatitis C, and communities affected by hepatitis C. We will also explore what lessons we could learn from our response to COVID-19 to achieve our hepatitis C goals.
Moderator: Shriya Hari, COVID-19 Information Specialist and Education Coordinator, CATIE
- Dr. Naveed Janjua, Executive Director, Data and Analytic Services, B.C. Centre for Disease Control, Clinical Associate Professor, UBC School of Population & Public Health
- Dr. Brian Conway, Medical Director, Vancouver Infectious Diseases Centre
- Mia Biondi, Nurse Practitioner/Researcher, Viral Hepatitis Care Network/Toronto Centre for Liver Disease, University Health Network
- Leona Quewezance, Program Director, All Nations Hope
- Candace King, Peer Support Worker, North Lambton Community Health Centre
Ce webinaire sera présenté en anglais et interprété en simultané en français.